Bridge Biotherapeutics' Series A Round

Bridge Biotherapeutics raised a round of funding on July 04, 2016.

Bridge Biotherapeutics (브릿지바이오) is a virtually-operated clinical stage global biotech company, headquartered in Seongnam, Korea with its subsidiary at JLABS@TMC. The company is engaged in …

Articles about Bridge Biotherapeutics' Series A Round: